S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES

• Michael Dickinson,
• Nada Hamad,
• Christian Bryant,
• Nishi Kothari,
• Paulius Ojeras,
• Anmol Vohra,
• Ming Lin,
• Mira Tohme,
• James Trager,
• David Shook,
• Glen Kennedy,
• Michael Tees,
• Brian T. Hill

Affiliations

Michael Dickinson

1 Peter MacCallum Cancer Centre, Melbourne, Australia

Nada Hamad

2 St Vincent’s Hospital Sydney, Darlinghurst, Australia

Christian Bryant

3 Royal Prince Alfred Hospital, Camperdown, Australia

Nishi Kothari

4 Nkarta, Inc., South San Francisco, United States

Paulius Ojeras

4 Nkarta, Inc., South San Francisco, United States

Anmol Vohra

4 Nkarta, Inc., South San Francisco, United States

Ming Lin

4 Nkarta, Inc., South San Francisco, United States

Mira Tohme

4 Nkarta, Inc., South San Francisco, United States

James Trager

4 Nkarta, Inc., South San Francisco, United States

David Shook

4 Nkarta, Inc., South San Francisco, United States

Glen Kennedy

5 Royal Brisbane and Women’s Hospital, Herston, Australia

Michael Tees

6 Colorado Blood Cancer Institute, Denver, United States

Brian T. Hill

7 Cleveland Clinic Main Campus, Cleveland, United States